Evaxion Biotech AS EVAX Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	41.08M	34M	27.45M	22.03M	20.49M	16.75M	11.94M	86.93M
Total Current Assets	31.41M	28.53M	17.85M	16.99M	10.24M	7.12M	2.61M	56.31M
Cash and Equivalents	31.41M	25.25M	17.85M	13.18M	10.24M	7.12M	2.61M	37.65M
Total Non-Current Assets	9.67M	10.2M	9.59M	9.72M	10.25M	9.64M	9.34M	59.91M
Total Liabilities	14.69M	13.85M	13.9M	13.72M	13.91M	14.22M	14.68M	118.82M
Total Current Liabilities	0	4.41M	0	3.76M	0	0	0	47.77M
Total Non-Current Liabilities	14.69M	18.75M	13.9M	19.78M	13.91M	14.22M	14.68M	141.1M
Common Equity	3.76M	3.84M	3.86M	3.89M	4.22M	4.39M	4.42M	37.9M
Retained Earnings	-55.88M	-60.33M	-65.76M	-72.66M	-78.72M	-84.26M	-89.76M	-721.6M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	11.08M	11.97M	40.16M	22.03M	86.93M
Total Current Assets	10.96M	10.95M	34.71M	16.99M	56.31M
Cash and Equivalents	9.56M	5.83M	32.17M	13.18M	37.65M
Total Non-Current Assets	9.36M	7.04M	32.44M	8.3M	-31.89M
Total Liabilities	1.72M	4.93M	7.73M	13.72M	118.82M
Total Current Liabilities	1.72M	4.93M	4.32M	3.76M	47.77M
Total Non-Current Liabilities	0	0	6.65M	19.78M	141.1M
Total Equity	9.36M	7.04M	32.44M	8.3M	-31.89M
Common Equity	2.48M	2.65M	3.76M	3.89M	37.9M
Retained Earnings	-15.81M	-27.28M	-50.43M	-72.66M	-721.6M